APOTHEEK VAN CLEEMPUT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK VAN CLEEMPUT
Largest movements
- Stocks and contracts +€77,627
up €77,627 (+24.4%), from €318,761 to €396,388
- Receivables within one year +€65,413
up €65,413 (+5.6%), from €1.2m to €1.2m
of which Other amounts receivable: +€62,435
- Tangible fixed assets -€34,117
down €34,117 (-4.8%), from €708,059 to €673,942
- Trade debts +€141,228
up €141,228 (+46.7%), from €302,193 to €443,422
- Gross operating margin +€19,890
up €19,890 (+7.7%), from €259,614 to €279,504
- Financial charges -€18,871
down €18,871 (-64.3%), from €29,355 to €10,484
- Depreciation +€14,435
up €14,435 (+41.6%), from €34,687 to €49,122
- Staff costs -€9,034
down €9,034 (-5.3%), from €170,647 to €161,613
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,458,175 | €2,569,998 | +€111,823 | +4.5% |
| Fixed assets | 21/28 | €723,009 | €688,892 | -€34,117 | -4.7% |
| Tangible fixed assets | 22/27 | €708,059 | €673,942 | -€34,117 | -4.8% |
| Land and buildings | 22 | €548,452 | €531,549 | -€16,903 | -3.1% |
| Plant, machinery and equipment | 23 | €156,521 | €140,278 | -€16,243 | -10.4% |
| Furniture and vehicles | 24 | €3,086 | €2,115 | -€971 | -31.5% |
| Financial fixed assets | 28 | €14,950 | €14,950 | = | 0.0% |
| Current assets | 29/58 | €1,735,166 | €1,881,106 | +€145,940 | +8.4% |
| Stocks and contracts in progress | 3 | €318,761 | €396,388 | +€77,627 | +24.4% |
| Stocks | 30/36 | €318,761 | €396,388 | +€77,627 | +24.4% |
| Amounts receivable within one year | 40/41 | €1,161,222 | €1,226,635 | +€65,413 | +5.6% |
| Trade receivables | 40 | €178,231 | €181,209 | +€2,978 | +1.7% |
| Other amounts receivable | 41 | €982,991 | €1,045,426 | +€62,435 | +6.4% |
| Cash at bank and in hand | 54/58 | €206,629 | €207,925 | +€1,295 | +0.6% |
| Deferred charges and accrued income | 490/1 | €48,554 | €50,158 | +€1,604 | +3.3% |
| Total equity and liabilities | 10/49 | €2,458,175 | €2,569,998 | +€111,823 | +4.5% |
| Equity | 10/15 | €1,013,759 | €1,015,254 | +€1,495 | +0.1% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €988,759 | €990,254 | +€1,495 | +0.2% |
| Tax-exempt reserves | 132 | €337 | €337 | = | 0.0% |
| Distributable reserves | 133 | €988,422 | €989,917 | +€1,495 | +0.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €1,444,416 | €1,554,744 | +€110,328 | +7.6% |
| Amounts payable after more than one year | 17 | €827,495 | €807,050 | -€20,445 | -2.5% |
| Financial debts | 170/4 | €827,495 | €807,050 | -€20,445 | -2.5% |
| Amounts payable within one year | 42/48 | €616,921 | €747,694 | +€130,773 | +21.2% |
| Current portion of amounts payable after more than one year | 42 | €19,588 | €20,445 | +€857 | +4.4% |
| Trade debts | 44 | €302,193 | €443,422 | +€141,228 | +46.7% |
| Suppliers | 440/4 | €302,193 | €443,422 | +€141,228 | +46.7% |
| Taxes, remuneration and social security | 45 | €34,643 | €39,403 | +€4,760 | +13.7% |
| Taxes | 450/3 | €6,027 | €7,460 | +€1,434 | +23.8% |
| Remuneration and social security | 454/9 | €28,616 | €31,943 | +€3,327 | +11.6% |
| Other amounts payable | 47/48 | €260,497 | €244,424 | -€16,073 | -6.2% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €170,647 | €161,613 | -€9,034 | -5.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €34,687 | €49,122 | +€14,435 | +41.6% |
| Other operating charges | 640/8 | €4,885 | €4,657 | -€228 | -4.7% |
| Gross operating margin | 9900 | €259,614 | €279,504 | +€19,890 | +7.7% |
| Operating profit (loss) | 9901 | €49,395 | €64,112 | +€14,717 | +29.8% |
| Financial income | 75/76B | €42,352 | €42,471 | +€119 | +0.3% |
| Recurring financial income | 75 | €42,352 | €42,471 | +€119 | +0.3% |
| Financial charges | 65/66B | €29,355 | €10,484 | -€18,871 | -64.3% |
| Recurring financial charges | 65 | €29,355 | €10,484 | -€18,871 | -64.3% |
| Profit (loss) for the period before taxes | 9903 | €62,392 | €96,099 | +€33,707 | +54.0% |
| Income taxes | 67/77 | €2,787 | €4,604 | +€1,817 | +65.2% |
| Profit (loss) for the period | 9904 | €59,605 | €91,495 | +€31,890 | +53.5% |
| Profit (loss) for the period to be appropriated | 9905 | €59,605 | €91,495 | +€31,890 | +53.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.